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Abstract
Genome wide association studies (GWAS) have emerged as popular tools for iden-
tifying genetic variants that are associated with disease risk. Standard analysis of a
case-control GWAS involves assessing the association between each individual geno-
typed SNP and disease risk. However, this approach suffers from limited repro-
ducibility and difficulties in detecting multi-SNP and epistatic effects. As an alter-
native analytical strategy, we propose grouping SNPs together into SNP sets based
on proximity to genomic features such as genes or haplotype blocks, and then test-
ing the joint effect of each SNP set. Testing of each SNP set proceeds via the logistic
kernel machine based test which is based on a statistical framework that allows for
flexible modeling of epistatic and nonlinear SNP effects. This flexibility as well as the
ability to naturally adjust for covariate effects are important features of our test that
make it appealing compared to individual SNP tests and existing multi-marker tests.
Using simulated data based on the International HapMap Project, we show that SNP
set testing can have improved power over standard individual SNP analysis under a
wide range of settings. In particular, we find that our approach has higher power than
individual SNP analysis when the median correlation between disease susceptibility
variant and the genotyped SNPs is moderate to high. When the correlation is low,
both individual SNP analysis and the SNP set analysis tend to have low power. We
apply SNP set analysis to analyze the CGEMS breast cancer GWAS discovery phase
data.
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1 Introduction
Identification of single nucleotide polymorphisms (SNPs) that are associated with risk for
developing complex disease is an important goal of modern genetic studies. The hope is
that such knowledge can ultimately be used both for understanding the biological mech-
anisms underlying these diseases and for generating individualized risk profiles that are
useful in a public health context. To this end, genome wide association studies (GWAS)
have emerged as a popular tool for identifying common genetic variants for complex
disease. A standard case-control GWAS for identifying SNPs associated with disease sus-
ceptibility involves genotyping a large number of SNPs, on the order of hundreds of
thousands, in thousands of individuals with the disease (cases) and thousands of healthy
controls with the goal of identifying individual loci that are associated with the outcome.
Such studies have been successfully used to identify SNPs associated with susceptability
to diseases such as breast cancer1, 2 (MIM 114480), prostate cancer3–5 (MIM 176807), and
type II diabetes6–8 (MIM 125853).
A typical GWAS consists a discovery phase in which an initial set of promising sus-
ceptibility loci are identified followed by a validation stage in which the SNPs identified
in the initial discovery phase are replicated in a separate study cohort.9 The standard
approach for analyzing GWAS in the discovery phase involves individual SNP analy-
sis. This mode of analysis often involves regressing the phenotype onto each individual
typed SNP and generating a parametric 푝-value. The SNPs are then ranked based on their
individual 푝-values and a threshold is set such that all SNPs with 푝-value less than that
threshold will be pushed forward for validation. The threshold can be based on reach-
ing a muliple-comparison adjusted significance level or a level based on non-analytical
means.
Although use of individual SNP analysis has proved useful in identifying many dis-
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ease susceptibility variants, this mode of analysis may be limited in some settings due to
difficulty in reaching genome wide significance. More specifically, in order to control the
overall type I error rate, the level at which each test is conducted must be adjusted. Due
to the large number of considered hypotheses, the threshold for genome wide signficance
can be very extreme and difficult to attain: for a GWAS examining the effects of 500,000
SNPs, each test is conducted at the 훼 = 10−7 level, which is very stringent.
Additionally, individual-SNP analysis is often limited by poor reproduceability; many
of the highly-ranked SNPs in the discovery phanes are false positives and cannot be vali-
dated. This is largely due to the restricted power to detect SNPs with small effects that are
truly associated with the outcome. In particular, individual SNPs that are genotyped on
GWAS platforms often show only modest effects. One explanation for this is that the true
causal SNP is rarely genotyped, but there are typed SNPs which are in linkage disequi-
librium (LD) with the causal SNP. In this case, using individual SNP analysis, the typed
SNPs in LD with the causal SNP will each only show moderate effects since each typed
SNP serves as an imperfect surrogate for the causal SNP. Thus, it could be advantageous
to consider the joint effect of multiple SNPs in analysis10 since it is probable that several
of these markers are in LD with the causal SNP and could capture the true effect more
effectively than individual-SNP analysis. Finally, individual SNP analysis only consid-
ers the marginal effect of each SNP and therefore fails to accommodate epistatic effects.
Epistatic interactions between SNPs can contribute to disease susceptibility such that in-
dividual SNPs may show little individual effect, but their interactions can have a much
larger effect. Individual SNP analysis will not be able to detect such effects which, more
generally, are difficult to find due to the large number of potential interactions.11
As an alternative strategy for analysis, we propose grouping of SNPs together into
SNP sets along the genome and perform genome-wide tests for individual SNP sets in-
stead of individual SNPs. SNP set based analysis borrows information from different but
2
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correlated SNPs that are grouped based on prior biological knowledge and hence has
the possibility of providing results with improved reproducibility and increased power,
especially when individual SNP effects are moderate, and improve interpretability of the
results. This mode of analysis proceeds via a two step procedure. First, SNPs are assigned
to SNP sets based on some meaningful biological criteria (genomic features), e.g., genes.
Then, tests for the association between each genomic feature and a disease phenotype are
performed using a logistic kernel machine based multilocus test, across the genome.
SNP set analysis can prove advantageous over the standard analysis of individual
SNPs. By forming SNP sets and testing each SNP set as a unit, we are reducing the num-
ber of hypotheses being tested and thus relaxing the stringent conditions for reaching
genome-wide significance. Grouping SNPs together properly, we will have improved
power in settings where SNPs are individually only moderately significant. In particu-
lar, though any single SNP may serve as a poor surrogate for an untyped causal SNP,
by considering multiple typed SNPs, we will be better able to capture the true effect of
the untyped causal SNP. Furthermore, if there are multiple independent causal SNPs, by
considering their joint effects, we will have power to detect their joint activity.
To test each SNP set within a case-control GWAS, we propose a general semiparamet-
ric kernel based testing procedure which is tailored towards high-dimensional genetic
data. Specifically, this test will combine the logistic kernel machine testing approach of
Liu et al.12 with the kernel framework suggested by Kwee et al.13 As we will show, the
logistic kernel machine has appealing features for SNP set analyses. The testing frame-
work is powerful and allows for great flexibility in the functional relationship between
the SNPs in a SNP set and the outcome. Thus, the method can easily account for complex
SNP interactions and nonlinear effects. Combined with the ability to seamlessly adjust
for covariate effects and the fast computational efficiency of our method, this flexibility
gives the logistic kernel machine based test significant advantages over both individual
3
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SNP tests and existing multi-marker tests.
Broadly speaking, our work advances the field in three important ways. First, we de-
velop SNP set analysis as an alternative to standard individual SNP analysis and discuss
principled approaches for forming SNP sets based on genomic features. Second, we de-
velop a powerful statistical modeling and testing framework for genetic effects which has
a number of practical advantages over other multi-marker tests: our approach is compu-
tationally efficient and naturally accommodates covariate adjustment, non-linear effects,
and epistasis. Third, we will demonstrate through thorough numerical studies and data
applications that our approach can have substantially improved power over standard in-
dividual SNP testing, and by extension, over the many multi-marker tests that individual
SNP testing tends to dominate.
The remainder of this article is organized as follows. In the next section, we describe
our proposed SNP set analysis framework including how to form SNP sets and how to
subsequently test SNP sets. Then we will present simulation results comparing our ap-
proach to individual SNP analysis and two existing multi-SNP tests. Finally, we will
apply logistic kernel machine based SNP set analysis to the CGEMS breast cancer data
from the discovery phase. We will conclude with a brief discussion.
2 Materials and Methods
SNP set based analysis borrows information from different but correlated SNPs that are
grouped based on prior biological knowledge and hence provides results with improved
reproducibility and increased power, especially when individual SNP effects are moder-
ate. This mode of analysis proceeds via a two step procedure. First, across the genome,
SNPs are assigned to a SNP sets based on some meaningful biological criteria such as
proximity to genomic features—SNP sets of a single SNP are possible. If we wished to
4
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perform genome wide SNP set analysis of a GWAS conducted on the Illumina Human-
Hap500 array by grouping SNPs based on genes, we could generate approximately 18000
SNP sets, each of which consisted of the SNPs within a single gene. For example, the 14
genotyped SNPs within the ASAH1 (MIM 228000) gene could be assigned to a single SNP
set and the 4 genotyped SNPs within the NAT2 (MIM 612182) gene could be assigned to
another SNP set, and so on. After the groupings are made, each of the 18000 SNP sets
is tested using a multilocus test, and the genome-wide significance of SNP set, e.g. each
gene, is calculated. Although a number of tests have been proposed,14, 15 we consider an
extension of the logistic kernel machine test, which was developed in the gene expression
profiling setting, that we tailor for analysis of genome wide association studies. In this
section, we describe possible methods for grouping SNPs in a genome wide scan into SNP
sets and then we present the logistic kernel machine test for evaluating the significance of
each SNP set.
2.1 Forming SNP Sets
A key aspect of our proposed approach is the formation of meaningful SNP sets. In prin-
ciple, a SNP set may be formed via any grouping of SNPs, and our testing approach is
still valid in the sense that the type I error rate will always be protected. However, better
groupings can be made on the basis of prior biological knowledge and if done properly,
can lead to additional gains in power. In particular, the key advantages of our approach
may be found in the ability to reduce the number of multiple comparisons, to harness
correlation between SNPs, to measure the joint effect of independent SNPs, and to make
direct inference on a biologically meaningful genomic feature. Some natural ways of
forming SNP sets that can capitalize on these advantages include grouping SNPs on the
basis of genomic features. We describe below some natural grouping structures.
A natural grouping strategy is to take all SNPs that are located in or near a gene, a
5
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fundamental unit of the genome, and group them to form a SNP set. In particular, one
can take all SNPs between the start and end of transcription as well as SNPs that are
upstream and downstream of the gene, in order to capture regulatory regions, as a single
SNP set. In grouping based on known genes, we can significantly reduce the number
of multiple comparisons. The SNPs on the Illumina HumanHap 500 array correspond
to to approximately 17,800 genes in contrast to the original 530,000 SNPs. Since we take
the entire gene region, not just exonic regions, we expect to have many typed SNPs that
are correlated and thus the logistic kernel machine test will have good power to detect
a significant SNP set effect. We could also expect multiple SNPs within a gene to be
associated with disease risk and this grouping structure would allow us to detect this
effect. Testing gene-based SNP sets also makes direct inference on the association between
the gene and case-control status.
An extension of gene based SNP set analysis is to group SNPs based on whether they
are located within a gene pathway from KEGG16 or a Gene Ontology Consortium func-
tional category.17 Making inference on a pathway further reduces the number of multiple
comparisons and still allows inference on a biologically meaningful unit. The logistic ker-
nel machine test will be able to harness local LD to have power and will, additionally, be
able to capture true pathway effects when several SNPs in multiple genes are related to
the disease.
Although many variants associated with disease have been identified within gene re-
gions, many lie outside of the boundaries of known genes (and hence pathways). To
augment coverage of the genome, a possible strategy would be to group SNPs within
evolutionarily conserved regions. Increased evolutionary conservation of a genomic re-
gion is suggestive of increased importance or functionality.18 Significance of such a SNP
set would potentially indicate that there is a genomic feature present that is related to
disease risk, even if the feature is not well understood.
6
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Finally, approaches to forming SNP sets that can achieve full coverage of the genome
by placing all SNPs into SNP sets include grouping SNPs via a moving window or via
haplotype blocks. For example, one could divide the genome into a fixed number of
adjacent regions, purely based on length, and treat all SNPs within a region as a SNP
set. Alternatively, one could build SNP sets based on haplotype blocks such as through
Haploview.19 Both approach will still allow us to harness local correlation to capture the
effect of untyped SNPs.
An important limitation of employing a gene or pathway based approach is the omis-
sion of intergenic regions. However, use of additional grouping strategies, e.g. conserved
regions, can augment coverage, and using the moving window and haplotybe block can
provide comprehensive coverage of the entire genome. Although we wish to group SNPs
that are near one another to harness correlation, this does not allow us to capture multi-
SNP or epistatic effects among SNPs in separate SNP sets. Using gene pathway based
SNP sets could ameliorate this issue since this looks across individual continuous regions.
Groupings based on strategies beyond the ones that we have considered are also possible.
As noted above, we emphasize that while well formed SNP sets can optimize the
power and interpretability of our SNP set testing strategy, our logistic kernel machine
testing approach is statistically valid irrespective of the grouping scheme. For illustration,
we will focus on SNP sets formed based on proximity to each of 18000 known genes.
2.2 Genome Wide SNP Set Testing
Although we propose our strategy as a genome wide approach, we will present the test-
ing procedure by focusing on testing a single SNP set.
In this paper, we assume that a population based case-control GWAS was conducted in
which 푛 independent subjects were genotyped. To employ our SNP set analysis approach,
we first group the SNPs into SNP sets across the genome. Then for a given SNP set
7
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containing 푝 SNPs, let 푧푖1, 푧푖2, . . . , 푧푖푝 be genotype values for the SNPs in the SNP set for
the 푖푡ℎ subject (i = 1,. . . ,n). The case-control status for the 푖푡ℎ subject is denoted by 푦푖
(푦푖 = 1 for cases and 푦푖 = 0 for controls). We assume without loss of generality that
the SNPs are coded in a trinary fashion with 푧푖푗 = 0, 1, 2 corresponding to homozygotes
for the major allele, heterozygotes, and homozygotes for the minor allele respectively.
This corresponds to the commonly employed additive model of allelic affect, but we note
that alternative models, such as the dominant and recessive models, are also possible
and can be tested within our framework. We further assume that for each individual,
an additional set of 푚 demographic, environmental, or other confounding variables is
collected. For the 푖푡ℎ subject we let 푥푖1, 푥푖2, . . . , 푥푖푚 denote the values of the covariates we
would like to adjust for. The goal of SNP set analysis is then to test the global null of
whether any of the 푝 SNPs are related to the outcome while adjusting for the additional
covariates.
In principle, many multi-locus testing approaches could be used for evaluating the
significance of the SNPs in the SNP set, but to harness correlation and accommodate
complex relationships between the SNPs and the outcome and epistatic effects, we pro-
pose a new approach to test the SNP set by modelling each SNP set’s effect in a flexible
fashion while adjusting for additional covariate effects. At the same time, to overcome
the issue of the large number of degrees of freedom, our strategy will employ a test that
adaptively estimates the degrees of freedom by accounting for correlation (LD) among the
SNPs. Specifically, we will choose to use the logistic kernel machine regression modelling
framework and a corresponding score test.12
2.2.1 Logistic Kernel Machine Model
In evaluating the significance of a SNP set, we need to employ a strategy that allows us
to model, and subsequently test, the effects of multiple SNPs that have been grouped
8
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in a biologically meaningful fashion. The kernel machine framework has become very
popular for modelling high-dimensional biomedical data due to its ability to allow for
complex/nonlinear relationships between the dependent and independent variables20, 21
while adjusting for covariate effects. We consider a logistic kernel machine regression
model for the joint effect of the SNPs in the SNP set and the additional covariates that
we would like to adjust for. Under the notation above, for the 푖푡ℎ individual, we have the
semiparametric model given by
logit푃 (푦푖 = 1) = 훼0 + 훼1푥푖1 + ⋅ ⋅ ⋅+ 훼푚푥푖푚 + ℎ(푧푖1, 푧푖2, . . . , 푧푖푝) (1)
where 훼0 is an intercept term, 훼1, . . . , 훼푚 are regression coefficients corresponding to the
environmental and demographic covariates. The SNPs, 푧푖1, . . . , 푧푖푝, influence 푦푖 through
the general function ℎ(⋅) which is an arbitrary function that that has a form defined only
by a positive semidefinite kernel function 퐾(⋅, ⋅).
Our primary aim is to adequately model the SNPs and evaluate their effect, so ℎ(⋅)
is the model component in which we have primary interest because it fully determines
the relationship between genotypes of the SNPs in the SNP set and disease risk. Leaving
ℎ(⋅) only generally specified permits a modelling framework that accommodates complex
relationships between the SNPs and risk as well as epistatic effects.
We omit the mathematical details, but using the representer theorem,22 we note that
ℎ(푧푖1, 푧푖2, . . . , 푧푖푝) in Equation 1 is equal to ℎ푖 = ℎ(Z푖) =
∑푛
푖′=1 훾푖′퐾(Z푖,Z푖′) for some
훾1, . . . , 훾푛. This shows that ℎ(⋅) is fully defined by the kernel function 퐾(⋅, ⋅). Details on
the mathematical relationships and estimation may be found in Liu et al.12 and Cristianini
et al.,20 but the key is that by choosing different kernel functions, we can specify different,
possibly complex, bases and corresponding models. For example, if we define 퐾(⋅, ⋅) to
be the linear kernel such that 퐾(Z푖,Z푖′) =
∑푝
푗=1 푧푖푗푧푖′푗 then we are implicitly assuming the
9
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simple logistic model defined by
logit푃 (푦푖 = 1) = 훼0 + 훼1푥푖1 + ⋅ ⋅ ⋅+ 훼푚푥푖푚 + 훽1푧푖1 + 훽2푧푖2 + ⋅ ⋅ ⋅+ 훽푝푧푖푝
where 훽푗 is a regression coefficient corresponding to the 푗푡ℎ SNP. To specify a more com-
plicated model, we need only change our choice of 퐾(⋅, ⋅).
From the above, it is apparent that the choice of kernel changes the underlying basis
for the nonparametric function governing the relationship between case-control status
and the SNPs in the SNP set. Essentially, 퐾(⋅, ⋅) is a function that projects the genotype
data from the original space to another space and then ℎ(⋅) is modelled linearly in this new
space, such that if one considers ℎ on the original space, it can be highly nonlinear. More
intuitively, however, 퐾(Z푖,Z푖′) can be viewed as a function that measures the similarity
between two individuals, the 푖푡ℎ and 푖′푡ℎ subject, based on the genotypes of the SNPs in the
SNP set. Taking this perspective, many choices for 퐾 are possible. Some specific kernels
functions that we can consider include the linear, identical-by-state (IBS), and weighted
IBS kernels.
The linear kernel is: 퐾(Z푖,Z푖′) =
∑푝
푗=1 푧푖푗푧푖′푗 which is the usual inner product between
the covariate vectors for subject 푖 and 푖′. As described earlier, this kernel assumes a set of
basis functions that spans the original covariate space such that one is implying a linear
relationship between the logit of the probability of being a case and the genotypes of the
SNPs in the SNP set, i.e. the usual multiple logistic regression model.
The gaussian kernel is: 퐾(Z푖,Z푖′ ; 푑) = exp{−
∑푝
푗=1(푧푖푗 − 푧푖′푗)2/푑} and assumes the
radial basis which is difficult to characterize using an explicit set of basis functions. The
class of models generated by the gaussian kernel can be very broad and includes the
linear model as a special case. Here 푑 is a parameter that approximately controls area
of influence of the kernel function such that larger values of 푑 correspond to smoother ℎ
10
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functions.
The IBS kernel is: 퐾(Z푖,Z푖′) =
∑푝
푗=1{2퐼(푧푖푗=푧푖′푗)+퐼(∣푧푖푗−푧푖′푗 ∣=1)}
2푝
. In genetics, a possible
metric for evaluating distance between individuals on the basis of genotype information
is the number of alleles shared identical by state (IBS) by a pair.15 As shown by Kwee et
al.,13 this may also be used a a valid kernel function.
The weighted IBS kernel is: 퐾(Z푖,Z푖′ ;w) =
∑푝
푗=1 푤푗{2퐼(푧푖푗=푧푖′푗)+퐼(∣푧푖푗−푧푖′푗 ∣=1)}
2푝
where 푤푗 =
1/
√
푞푗 and 푞푗 is the minor allele frequency (MAF) for the 푗푡ℎ SNP in the SNP set. The
weighted IBS kernel is an extension of the IBS kernel that up-weights for similarity in
rare alleles. The idea is that similarity in rare alleles is more informative than similarity
in common alleles.
The ability to model data using the gaussian and IBS kernels are advantages of using
the kernel machine framework since formulating an explicit set of basis functions can be
difficult. Alternative kernel functions, such as those discussed in Wei and Schaid23 and
in Mukhopadhyay et al.24 are possible and can be designed for specific data sets. To be a
valid kernel function, 퐾(⋅, ⋅) needs to be positive semi-definite and satisfy the conditions
of Mercer’s theorem.20
2.2.2 Logistic Kernel Machine Test
Here, our focus is on hypothesis testing for which only need to estimate 훼 under the null
hypothesis that ℎ(Z푖) = 0. Therefore, we omit the technical details on estimating the
genetic effect, ℎ(Z), from the SNP set and refer the reader to Liu et al.12
The above modelling framework leads naturally to a powerful test for association
between the SNPs in the SNP set and case-control status. Note that the probability that
the 푖푡ℎ subject is case depends on the SNPs only through the function ℎ(Z푖). Thus, in order
11
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to test whether there is a true SNP set effect, we can consider the null that
퐻0 : h(Z) = 0 (2)
against the general alternative. To test this hypothesis, Liu et al.12 exploit the connection
between the kernel machine framework and generalized linear mixed models (GLMM).
Specifically, letting K be the 푛 × 푛 matrix with (푖, 푖′)푡ℎ element equal to 퐾(Z푖,Z푖′), then it
is straightforward to see that h = K휸, where h = [ℎ1, . . . , ℎ푛]′. We can treat h as a subject
specific random effect, then via the GLMM connection, h follows an arbitrary distribution
퐹 with mean zero and variance 휏K. Note that 휏 indexes the effect of the SNPs in the SNP
set such that
퐻0 : ℎ(Z) = 0⇔ 퐻0 : 휏 = 0.
Thus, we need only to test whether the indexing parameter 휏 is significantly different
than zero. This can proceed via the variance component score test of Zhang and Lin25
using the statistic:
푄 =
(y − pˆ0)′K(y − pˆ0)
2
(3)
where logit 푝ˆ0푖 = 훼ˆ0 + 훼ˆ1푥푖1 + 훼ˆ2푥푖2 + ⋅ ⋅ ⋅+ 훼ˆ푚푥푖푚. Since this is a score test, 훼ˆ0 and the 훼ˆ푗
are estimated under the null model which does not contain h, so we can use the standard
estimate from the logistic regression model without the genotypes. To compute a p-value
for significance, we can compare푄 to a scaled 휒2 distribution with scale parameter, 휅, and
degrees of freedom, 휈. Details on calculating 휅 and 휈 are found in the Appendix.
The adaptive estimation of the degrees of freedom, 휈, constitutes a key advantage of
the logistic kernel machine test. In particular, if the 푅2 between the SNPs in the SNP
set increases, then 휈 decreases such that if all the SNPs are perfectly correlated, 휈 →
1. It follows that for a given ℎ(⋅), higher correlation is likely to lead to higher power,
12
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suggesting that the logistic kernel machine test improves the power for SNP set testing
by harnessing the correlation between SNPs and adaptively estimating 휈.
In general, it can be difficult to identify a prior whether it is the minor allele or the
major allele that is associated with increased disease risk, and equivalently, whether the
minor allele is protective or deleterious. The logistic kernel machine test is not affected
by the directionality of effect and its power is robust to whether the minor alleles of the
causal SNP are protective or deleterious (or a combination of both in settings with multi-
ple causal variants).
The testing framework considered here has similarities to those of Schaid et al.,10
Mukhopadhyay et al.,24 and Wessel and Schork15 which we describe below in that all
three approaches are based on genetic distances among subjects. However, the kernel
framework allows for improved flexibility in the functional relationship.
2.2.3 Existing Multi-SNP Tests
Although other multi-SNP tests could be used for evaluating the significance of each SNP
set, the kernel machine has advantages over each of these. Here, we briefly discuss some
alternative tests that fall into several different categories.
The first class of multi-SNP test encompasses the multi-marker methods that are based
on individual SNP analysis. In particular, a common approach for evaluation the signif-
icance of a set of markers is to apply individual SNP analysis by testing the individual
significance of each SNP, using the most significant 푝-value as the 푝-value for the set of
loci, and then correct for having done multiple tests via monte carlo methods26 or by esti-
mating the effective number of tests.27–29 Alternatively, the test statistics from each of the
individual tests can be combined.30 However, such tests still rely strongly on individual
SNP analysis and when the individual SNPs are not in high LD with the causal variant,
they may have low power, as they do not borrow information across SNPs which are fre-
13
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quently correlated. Furthermore, they cannot accommodate complex genetic effects and
interactions. Our simulations will verify that the logistic kernel machine test often has
improved power over this class of test.
Omnibus tests for multiple SNPs or haplotypes via multivariate regression10, 31 allow
for simultaneous analysis of all SNPs, butstudies have shown that such methods often
offer little benefit over individual SNP analysis based methods32, 33 as they are based on
a large number of degrees of freedom. To reduce the degrees of freedom, a set of multi-
marker tests that compare pairwise genetic similarity with pairwise trait similarity were
proposed by Schaid et al.,14 Wessel and Schork,15 and Mukhopadhyay et al.24 All three
approaches are attractive; however, as noted by Mukhopadyay et al., an important limi-
tation of Schaid et al.’s approach is that it assumes all variants have the same direction of
effect, i.e. all the minor alleles for each SNP increase risk or all minor alleles decrease risk.
Although the methods of Wessel and Schork and Mukhopadhyay et al. are robust to di-
rectionality, both evaluate significance via computationally expensive permutation which
may be impractical for some GWAS settings. None of the three similarity based meth-
ods allow for easy covariate adjustment. The logistic kernel machine test also considers
pairwise similarity and shares the attractive nonparametric SNP effects model, but in ad-
dition to using a computationally efficient score test and being robust to directionality,
the logistic kernel machine model naturally incorporates covariate effects, an important
feature. Beyond adjusting for confounders and population structure, it is often neces-
sary to adjust for highly significant SNPs in GWAS to distinguish between settings where
a particular significant marker is the causal SNP (or a SNP in high LD with the causal
SNP), versus setting where additional independent markers that are associated with dis-
ease are present. A third similarity based approach by Tzeng and Zhang34 can be seen
as a special case of the more general logistic kernel machine test that focuses exclusively
on haplotype similarity. The need to phase sample haplotypes from genotype data incurs
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additional computational expense and variability—particularly for larger SNP sets.
A final class of multi-marker tests consists of methods that leverage explicit popula-
tion genetic models to pinpoint the causal locus. Many involve reconstructing the sample
phylogeny to guide the analysis and infer the causal mutation.35, 36 If the population ge-
netics model assumed is realistic and correct, such problem specific methods should have
high power. However, it is difficult to validate the assumed models and most proce-
dures are computationally intensive such that in real applications the models need to be
simplified. Once again, these models usually fail to allow for covariate adjustment. Com-
putational efficiency and ease of covariate adjustment give a practical advantage to the
logistic kernel machine regression test.
2.3 Simulations
To evaluate the performance of our SNP set analysis approach, we study the logistic ker-
nel machine test in the genetics framework by considering its empirical performance un-
der a variety of settings. For simplicity of implementation, all causal SNPs in our simu-
lations are assumed to increase disease risk, but it is important to note that none of the
methods we consider are affected by the direction of effect.
2.3.1 Simulations Based on the ASAH1 Gene
We first investigate the size and power of the kernel machine testing framework under a
setting in which the SNP set is generated based on the LD structure of a single gene which
will allow us to better understand under which settings our SNP set analysis approach is
most advantageous. We considered the ASAH1, NAT2, and FGFR2 (MIM 176943) genes,
but for clarity, we present only the simulation configurations and the results based on
the ASAH1 gene. The simulations and results from using the NAT2 and FGFR2 were
qualitatively similar.
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ASAH1, acid ceramidase 1, is a 28.5kb long gene with 86 HAPMAP SNPs and is lo-
cated at 8p21.3-p22. Expression is associated with prostate cancer37 and mutations in the
gene are known to be associated with Farbers Disease38 (MIM 228000). We based our gene
specific simulations on the LD structure of the ASAH1 gene and used HAPGEN39 and the
CEU sample of the International HapMap Project40 to generate SNP genotype data at each
of the 86 loci.41 14 out of 86 SNPs are genotyped using the Illumina HumanHap500 array.
These will be the “typed” SNPs we use for our simulated analysis.
We first conducted simulations to verify that the logistic kernel machine test properly
controls the type I error rate. To investigate the empirical size of our test, we conducted
simulations in which we generated 푛/2 cases and 푛/2 controls under the null logistic
model where disease risk does not depend on the genotype:
logit푃 (푦푖 = 1∣X푖) = 훼0 +휶′X푖 (4)
where X푖 is a vector of additional covariates that are independent of the simulated geno-
type data. We considered 푛 = 1000, 2000 and also considered the use of the linear, IBS,
and weighted IBS kernels. For each choice of 푛 and kernel function we generated 5000
data sets using HAPGEN. To ensure that our simulations are realistic, our simulations
generated all 86 HapMap SNPs, but we only apply our testing approach to the 14 typed
SNPs. Specifically, we group the 14 SNPs as a SNP set based on the ASAH1 gene and
then we apply the logistic kernel machine test to compute a p-value evaluating the effect
of the SNPs in the SNP set while adjusting for covariates in X. For comparison, we also
analyzed the 14 typed SNPs as we would have done under an individual SNP analysis:
we tested the significance of each of the 14 SNPs individually, while again adjusting for
covariates in X, and then adjusted the individual p-values via a modified bonferroni cor-
rection where the effective number of tests was computed via two approaches. First, we
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used the method of Moskvina et al.;29 second, we estimated the effective number of tests
as the number of principal components necessary to account for 99% of the variability.42
The two approaches were approximately concordant. The smallest p-value, corrected for
the effective number of tests, was was taken as the p-value for the entire SNP set. Size for
individual SNP analysis testing was again the proportion of p-values less than 훼 = 0.05.
To compute the empirical power for a SNP set, we generated data sets with 푛/2 cases
and 푛/2 controls under the alternative logistic model:
logit푃 (푦푖 = 1∣X푖) = 훼0 +휶′X푖 + 훽푐푧푐푖 (5)
where 푧푐푖 is the genotype for the “causal” SNP, 훽푐 is the log genetic odds ratio for the
causal SNP, and X푖 are a vector of additional covariates that are independent of 푧푐푖 . Note
that under each simulation configuration we allow only a single causal SNP. Each of the 86
HapMap SNPs was set to be the “causal” SNP in turn. Setting 훽푐 = 0.2 which corresponds
to a genetic odds-ratio of 1.22, we again considered sample sizes 푛 = 1000, 2000. For
each choice of 푛, and for each of the 86 causal SNPs, we generated 2000 data sets. We
again apply our testing approach to each data set by grouping the 14 typed SNPs and
computing a p-value for the significance of the SNP set, while adjusting for covariates in
X, via the logistic kernel machine test under a linear kernel. We emphasize that only the
14 typed SNPs were used so the causal SNP is unobserved under most configurations.
For each configuration, we then computed the test power as the proportion of 푝-values
less than the 훼 level = 0.05. This was compared with the power based on the individual
SNP analysis with modified bonferroni correction approach described above.
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2.3.2 Simulations Based on Randomly Sampled Genes
We also evaluate the power of our approach under settings in which the LD structure
of the simulated SNP sets varied across a wide range of possible genes. Specifically, we
generated 20,000 SNP sets using HAPGEN where each SNP set is based on a real gene on
chromosome 10. This allows for 670 possible SNP sets. Within each SNP set, we randomly
selected one HapMap SNP to be the causal SNP and again generated 푛/2 cases and 푛/2
controls based on model given by Equation 5 with 훽푐 again fixed at 0.2 (OR = 1.22). Again
treating the SNPs on the Illumina HumanHap 500K array as the typed, we tested the
significance of the SNP set using the logistic kernel machine test under a linear kernel.
We also apply the individual SNP analysis testing procedure described above. Thus, for
both our method and the competing individual SNP analysis test, we computed 20,000
p-values for significance.
2.3.3 Comparisons with Alternative Multi-SNP Tests
As discussed previously, in principle, any multi-SNP test can be used to test the signifi-
cance of a SNP set. However, the kernel machine test is advantageous in that it adaptively
finds the degrees of freedom of the test statistic in order to account for LD between geno-
typed markers, can permit complex relationships between the SNPs and the outcome,
naturally allows for covariate adjustment, and is computationally efficient since no per-
mutation is required. To provide additional empirical results, we compare the logistic
kernel machine test to the similarity based testing approach of Mukhopadhyay et al24
and the approach of Wessel and Schork,15 which has been found to perform well relative
to other multi-SNP tests.23 We assessed the power under five models and the test size
under two additional models. For each of the five models examining power, 500 sim-
ulations were conducted, and 1000 simulations were conducted under the two models
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examining the test size. For all seven models, we assumed sample sizes of 500 case and
500 controls, 1000 permutations were used to compute the 푝-values for the methods of
Wessel and Schork and Mukhopadhyay et al., and power and size were computed as the
proportion of 푝-values less than 0.05.
We first compare the power of the methods under four alternative models using SNP
sets based on the ASAH1 gene. Under Model 1, the data sets were simulated under the
alternative logistic model based on Equation 5 in which the causal variant was fixed to
be rs3810 (the third in the SNP set), one of the 14 typed SNPs, with 훽푐 again fixed at
0.2 (OR = 1.22). Model 2 was similar to Model 1, except we change the causal SNP to
be rs7825389 (the 69푡ℎ SNP), an untyped SNP. Model 3 was again similar to the earlier
models, except we allow for two causal variants, rs10105871 and rs7825389, which are the
63푟푑 and 69푡ℎ SNPs in the ASAH1 SNP set, respectively. Both SNPs are in the same LD
block and rs10105871 is typed while rs7825389 is untyped. The effect size for both causal
SNPs was set at 0.2. Model 4 is identical to Model 3, but here we have two untyped causal
SNPs which are in different LD blocks, rs4377998 and rs7825389, which are the 43푟푑 and
69푡ℎ SNPs respectively.
Under Model 5, we compared the power under the setting considered by Mukhopad-
hyay et al. in which 10 independent markers in Hardy-Weinberg equilibirium with MAF
= 0.05 are simulated. Two of the ten markers were causal with relative risks of 1.25 under
an additive model, and all 10 markers were considered to be genotyped. No additional
covariates are present.
We compare the type I error rate control of the logistic kernel machine test and the
approaches by Wessel and Schork and Mukhopadhyay et al. Specifically, under Model 6,
we simulated null data sets based on Equation 2 and the ASAH1 gene. We applied both
approaches to each of the data sets to estimate 푝-values for the significance of the SNPs
in the SNP set, and the size at the for each approach was estimated as the proportion of
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푝-values less than the 0.05 significance level. Under Model 7 is similar to Model 6, but we
generate an additional demographic covariate that is correlated with rs3810 (휌 = 0.065),
the third SNP in the SNP set.
2.4 CGEMS Breast Cancer Data
To demonstrate the applicability and power of our approach on real data, we apply SNP
set analysis to real GWAS data and contrast our results with those found under individual
SNP analysis.
The Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer study1 was con-
ducted to identify individual SNPs associated with breast cancer risk. To this end, in the
discovery phase, 1,145 cases with invasive breast cancer and 1,142 controls were geno-
typed at 528,173 loci using an Illumina HumanHap500 Array. All subjects were post-
menopausal women of European ancestry recruited from the Nurses Health Study. The
results of the top SNPs from the discovery phase are given in Table 2. In the initial vali-
dation study, the top 6 SNPs as well as two others in the FGFR2 gene were genotyped in
an independent set of 1,776 cases and 2,072 controls. A SNP within FGFR2 was validated
and found to be associated with risk of breast cancer. Note that the SNPs in FGFR2 were
not the top ranked variants and that the variants within FGFR2 do not reach genome wide
significance using either the bonferroni correction or an FDR correction in the initial scan.
To evaluate the performance of SNP set analysis with the logistic kernel machine based
test by applying it to reanalyze the CGEMs Breast Cancer Data. Specifically, we formed
SNP sets by grouping SNPs that lie within the same gene. To ensure that SNPs with
possible gene regulatory roles were also included in the SNP sets, all SNPs from 20kb
upstream of a gene to 20kb downstream of a gene were grouped. Using these criteria we
were able to assemble a total of 17,774 SNP sets that consisted of 310,219 unique typed
SNPs. We tested each of the gene based SNP sets using the logistic kernel machine test
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under the linear kernel, the IBS kernel, and the weighted IBS kernel. SNPs were coded in
the additive mode and we adjusted for parametric effects of age group, whether the indi-
vidual had hormone therapy, and the first four principal components of genetic variation
to control for population stratification.43
3 Results
3.1 Empirical Size and Power Based on the ASAH1 Gene
The size results for the logistic kernel machine test and individual SNP analysis are pre-
sented in Table 1. Based on our simulations, the logistic kernel machine test has correct
size for the kernels and sample sizes corrected and therefore, our overall strategy of logis-
tic kernel machine based SNP set analysis protects the type I error rate. Individual SNP
analysis with modified bonferroni correction also has correct size. As expected, the av-
erage effective number of tests over the 5000 replicates was stable irrespective of sample
size: 8.22 for 푛 = 1000 and 8.23 for 푛 = 2000.
We present the empirical power results for simulation based on the ASAH1 gene in
the top panel of Figure 1. The power for each testing approach and sample size is shown
for each of the 86 HapMap SNPs acting as the causal SNP. Based on Figure 1, we can
see that both methods have power when the causal SNP is in moderate or high LD with
the 14 typed SNPs. In these settings, the power for our logistic kernel machine SNP set
analysis approach tends to dominate individual SNP analysis for both considered sample
sizes suggesting that our testing approach is an attractive alternative or auxiliary method
to individual SNP analysis. For settings in which the causal SNP was not in LD with the
typed SNPs, the power was approximately at the type I error rate as we would expect.
For the purpose of clarifying the optimal conditions for our testing approach, Figure
21
Hosted by The Berkeley Electronic Press
2 shows the power for each testing approach and sample size is again presented, but here
the causal SNPs on the horizontal axis are ordered by the median 푅2 of the causal SNP
with the 14 typed SNPs. The median 푅2 between the causal SNP and the 14 typed SNPs
is plotted in the bottom panel. It is evident from the plots that the power for both testing
approaches grows as a function of the median 푅2 between the causal SNP and the typed
SNPs. On the right side of the plot where the median 푅2 is moderate to high, the ker-
nel machine based testing tends to have dramatically improved power over individual
SNP analysis even when the causal SNP is genotyped. When the median 푅2 is low, nei-
ther approach has much power. We emphasize that we consider the median 푅2 and not
the maximum and note that the power for the kernel machine test is not necessarily the
highest for situations in which the causal SNP is typed.
We repeated the size and power calculations based on theASAH1 gene for SNPs coded
in a dominant model (results not shown). We also repeated power calculations for SNP
sets with LD structure based on the FGFR2 and NAT2 genes. The size was again correct
and power plots are qualitatively similar.
The empirical studies show that logistic kernel machine based SNP set analysis pro-
tects the type I error rate. Furthermore, except for SNPs in low LD with the genotyped
SNPs (for which neither method has any power beyond the type I error rate and hence
any differences in power are random), the kernel machine based SNP set analysis has
greater power than individual SNP analysis.
3.2 Empirical Power Based on Randomly Sampled Genes
To summarize our results, we divide the 20,000 simulations into three groups based on 푝,
the number of typed SNPs with the SNP set. Essentially, we compute power after binning
the 20,000 simulations based on the SNP set size and then the median 푅2 between the
causal SNP and the typed SNPs. More specifically, we split the simulations in groups
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where 푝 ≤ 10, where 10 < 푝 ≤ 20, and where 20 < 푝. Then we further divided each of the
three groups into subgroups by sorting the simulated SNP sets based on the median 푅2
between the causal SNP and the typed SNPs and then splitting the group into 50 evenly
sized subgroups. Within each subgroup, we estimated the power as the proportion of
p-values less than 훼 = 0.05. For each of the groups, we plot the kernel density smoothed
power against the median 푅2 for the subgroups in Figure 3. We need to divide the SNP
sets based on the number of SNPs because distantly located SNPs are uncorrelated such
that the median 푅2 decreases with increased numbers of typed SNPs.
The plots verify the earlier result we found that the power increases as a function of the
median푅2 between the causal SNP and the typed SNPs. If the causal SNP is uncorrelated
with most typed SNPs then we have little power to detect the SNP set effect, but if there
is any power, then the kernel machine based SNP set analysis method again tends to
have higher power than individual SNP analysis. Both the overall power and the relative
power of our approach to individual SNP analysis increases as the number of typed SNP
increases. This again indicates that our approach may be a better alternative to individual
SNP analysis.
3.3 Multi-SNP Test Comparison Results
The results comparing the power and type I error rates of the logistic kernel machine test
and the Wessel and Schork approach are presented in Figure 4. As expected, if the num-
ber of independent causal SNPs is increased, the power for both approaches increases.
Across the first 4 models which compare the empirical power under practical settings
based on the ASAH1 gene, the logistic kernel machine test tends to have higher power
than both the Wessel and Schork method, with a gain of approximately 12-18%, and the
approach of Mukhopadhyay et al., which improves little over the type I error rate. Under
Model 5, which assumes common MAF and no LD among typed SNPs within a gene and
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2 causal SNPs that are genotyped, the logistic kernel machine test and Mukhopadhyay et
al.’s approach perform similarly, and both have considerably higher power than the Wes-
sel and Schork method. Overall, these results suggest that the logistic kernel machine test
has optimal power relative to other multi-SNP tests across different patterns of LD. More
interesting are the simulations comparing the type I error rate. When the demographic
and environmental covariates were simulated independently of the genotype informa-
tion, the size for all three tests is correct. However, when we set correlation between the
covariates, which is associated with the outcome and the genotypes to be modest (0.065),
failing to account for the covariates using the Wessel and Schork and Mukhopadhyay et
al. methods can possibly lead to an apparently inflated type I error rate of 25% and 10%,
respectively. This illustrates the importance of evaluating the significance of SNP sets
while in the presence of possible confounders.
Additional power simulations based on the ASAH1 gene in which as many as 4 causal
SNPs were used did not yield qualitatively different results in that the logistic kernel
machine test tended to have higher power. As this is unlikely to be a realistic situation,
given the rarity of risk-associated common variants and the relatively small regions, these
results are omitted.
We note that Mukhopadhyay et al.’s approach has similar power to the logistic kernel
machine test under Model 5. This is a setting that is favors their approach. In partic-
ular, the method of Mukhopadhyay et al. is based on an ANOVA model that assumes
that the effects of the modeled SNPs are constant and the residual correlation among ker-
nel similarity scores is the same across all different pairs of cases or controls considered.
Consequently, the method of Mukhopadhyay et al. will have excellent power when these
modeling assumptions hold but may lose power when such assumptions are violated,
such as under Models 1 through 4. The logistic kernel machine test does not make the
same assumptions as the method of Mukhopadhyay et al.; for example, the effect sizes of
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the modeled SNPs and MAFs are allowed to vary in our approach.
Since the power of the logistic kernel machine tends to be comparable or higher, and
given the difficulties posed by failing to adjust for demographic and environmental co-
variates and the additional computation cost incurred by permutation, the logistic kernel
machine test appears to be an attractive approach for testing the significance of SNP sets.
3.4 CGEMs Breast Cancer Data Analysis Results
The results of our reanalysis may be found in Table 3. Using our approach and the linear
kernel, we see that the SNP set formed of genetic variants close to the FGFR2 is now the
most highly ranked SNP set with p-value equal to 7.69×10−7 and FDR q-value equal to
0.01. At that signficance level, it also reaches genome wide significance if we apply a
bonferroni correction (훼 = 0.05/17, 774 = 2.8 × 10−6) or if we control the false discovery
rate. Using a bonferroni correction, FGFR2 again reaches genome wide significance if we
apply use the IBS kernel, and if we control the FDR at 5% it reaches significance with the
weighted IBS kernel as well.
4 Discussion
In this article, we propose logistic kernel machine based SNP set analysis as an approach
for the analysis of case-control genome wide association studies. Our approach employs
prior biological knowledge to group multiple SNPs that are located near genomic features
into SNP sets and then tested as a single unit. Specifically, we choose to model the SNPs
in the SNP set using a flexible semiparametric modelling framework which is based on
kernel machines and we choose to test the effects of the SNP set via a powerful variance
components test. We illustrate our approach using both data simulated from the Inter-
national HapMap Project40 as well as the CGEMS Breast Cancer GWAS study of Hunter
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et al.1 and showed that our approach is an attractive alternative or auxiliary approach to
individual SNP analysis.
The logic behind our analysis strategy is that we can borrow information between
different SNPs to improve power to detect true effects. Thus the choice of grouping can
influence the power of our approach. We focused on grouping SNPs based on their prox-
imity to a known gene and noted that this allowed us to reduce multiple comparisons
and harness local LD structure to improve power to capture untyped SNPs. Using genes
as the genomic features of interest allows us to map approximately 310K SNPs to 18K
SNP sets. However, it may be that the causal SNP lies far from a known gene in which
case groupings based on genes (and pathways by extension) will fail to capture the effect
of interest. To augment coverage of gene desert regions, we can group SNPs based on
additional genomic features such as evolutionarily conserved regions. Such groupings
again allow us to harness local correlation. The moving window approach will be useful
for capturing all genotyped SNPs, but direct interpretation of SNP set analysis results are
more difficult, though this may not be important. Groupings via haplotype blocks are at-
tractive since they make explicit use of the LD information. Use of haplotype blocks will
allow for comprehensive coverage of the entire genome and remove the need to explicitly
predefine genomic features of interest.
Beyond harnessing local LD structure to boost power, another important feature of our
approach is the ability to model the joint effect of multiple independent causal signals
as well as possible epistatic effects. Practically, however, finding a SNP set formation
strategy that optimizes for this can be difficult. Using a gene or moving window strategy
can certainly capture multi-SNP and epistatic effects among SNPs that are located close
to one another on the genome, but identification of such signals among SNPs that are
distantly placed will not be possible. A potential strategy is to use existing prior biological
knowledge. In particular, if multiple SNPs are expected to affect the disease risk, it is
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not unreasonable to expect them to lie within genes in the same pathway or genes with
similar function; hence, forming SNP sets based on pathways can potentially capture such
effects. Unfortunately, a systematic approach for identifying such grouping structures
at the genome wide level is not obvious. To avoid bias in our testing procedure, any
grouping strategy must be made without consideration of the case-control status of the
subjects in the data set. Thus, groupings must be made using information from external
sources, prior studies, or unsupervised statistical methods. As such, SNP set formation
strategies will improve with advances in our knowledge of the genome and genomic
structures.
Although we focused our power simulations on the linear kernel, our simulation re-
sults nevertheless suggest that our approach is as powerful as individual SNP analysis
and our approach can often have improved power over both the individual SNP analysis
strategy and other multi-SNP testing methods. In particular, we are able to show that
when the causal SNP is correlated with multiple typed SNPs, our approach has higher
power than individual SNP analysis. In settings where the causal SNP is not correlated
with multiple typed SNPs, simulations show neither individual SNP analysis nor our ap-
proach will be able to detect an effect. Recall that, here, the term individual SNP analysis
refers to correcting the smallest individual 푝-value for the SNPs in the SNP set for multi-
ple comparisons and using the adjusted 푝-value as the 푝-value for the entire SNP set. The
minimum uncorrected 푝-value for a SNP set may be smaller than the 푝-value from the lo-
gistic kernel machine test but would lead to significantly inflated type I error rate. Under
several settings, we found the kernel machine test tended to have improved power over
competing multi-SNP tests while naturally allowing for covariate adjustment to protect
the type I error rate when confounders are present.
We noted earlier that the linear kernel corresponds to the usual simple logistic model
whereas the IBS and weighted IBS are kernels tailored specifically to genetic data and the
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quadratic kernel is potentially useful for modelling epistatic effects. In fact, when epistatic
effects are present, the IBS kernel can allow for dramatically improved power over the
linear kernel. The ability to allow for complex relationships between the SNPs by just
specifying a single distance metric is an attractive feature of our approach. In practice,
however, one needs to choose a kernel a priori. Although our simulations demonstrated
that the size of our test is correct irrespective of the kernel used, the power will be in-
fluenced by the choice of kernel. The best way to choosing a kernel to use is unclear
since methods using the data to be tested are likely to overfit and simulations may reflect
the process under which the data were simulated. Our experience in simulations and
real data applications suggests using the linear kernel for testing SNP sets in which no
epistatic effects are anticipated (such SNP sets based on short regions) and the IBS kernel,
otherwise. Our experience is that there is a small loss in power for using the IBS kernel
when the true effect is linear, but potentially a considerable loss in power when the true
effect is complex/epistatic and the linear kernel is applied. Future research is necessary
to study the power using other types of kernels.
Our numerical results lead us to recommend our kernel machine approach for per-
forming multi-SNP analysis across a range of realistic settings. We have shown that it has
more power compared to existing popular approaches. It also has the ability to adjust for
covariates. This is particularly attractive since one usually needs to control for possible
population stratification and additional confounders in association studies. As noted by
Mukhopadhyay et al.,24 the performance of individual multi-SNP tests can depend on a
range of factors including the number of causal SNPs, effect size, and LD structure. Fu-
ture research is needed for more comprehensive comparisons, e.g. in other settings and
with other multi-SNP methods.
For a SNP set that is significantly associated with disease susceptibility, it is of great in-
terest to subsequently perform fine mapping and identify the individual causal variants.
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One strategy that can be used is to apply a variable selection procedure to select the “most
important” SNPs. For instance, one could use a LASSO penalized logistic regression44 to
regress the case-control status on the 14 SNPs in the ASAH1 SNP set. LASSO penalized
logistic regression will cause some of the regression coefficients to be estimated as ex-
actly zero, dropping the corresponding variables from the model. Such a strategy has
been used by others.45–47 However, existing variable selection literature does not allow
for selection of features within the logistic kernel machine regression framework in the
presence of SNP-SNP interactions. The optimal strategy for quantifying the contributions
of individual SNPs remains an area of considerable interest.
In addition to being able to account for complex SNP effects and adjust for covariates,
the key advantage of the logistic kernel machine test is the ability to adaptively estimate
the degrees of freedom. As discussed earlier, when the genotyped SNPs are highly cor-
related, the degrees of freedom of the test remain approximately constant. As a result,
the strength of our method can increase as progress in genotyping technology allows for
denser screens.
Appendix
Approximating the Null Distribution of the Score Statistic for the Logis-
tic Kernel Machine Test
The score statistic 푄 defined by Equation 3 tests the null hypothesis that 퐻0 : 휏 = 0
and is based on the variance components tests developed by Zhang and Lin48 and Lin49
and adapted by Liu et al.12 Note that this is a boundary case, so the null distribution
for 푄 follows a complex mixture of 휒2. This can be approximated via the Satterthwaite
method50 as a scaled chi-squared distribution, 휅휒2휈 , where the scale parameter, 휅, and
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the degrees of freedom, 휈, are calculated via moment matching. Specifically, for D0 =
diag(푝ˆ0푖(1− 푝ˆ0푖)) and P0 = D0 −D0X(X′D0X)−1X′D0, we define 휇푄 = tr(P0K)/2, 퐼휏휏 =
tr(KP0KP0)/2, 퐼휏휎 = tr(P0KP0)/2, 퐼휎휎 = tr(P0P′0)/2, and 퐼˜휏휏 = 퐼휏휏 − 퐼2휏휎/퐼휎휎. Then
휅 can be estimated as 휅 = 퐼˜휏휏/(2휇푄) and we can calculate the p-value for significance
by comparing 푄/휅 to a chi-square distribution of 휈 degrees of freedom, 휒2휈 , where 휈 =
2휇2푄/퐼˜휏휏 . The original derivation of our score test can be found in Lin,
49 where the link
function in Equation 2 of Lin is assumed to be the logit and the design matrix (Z) is set
to be K1/2. Our score statistic, 푄, in Equation 4 is identical to the first term of the score
statistic, 푈 , from Equation 8 of Lin (as D˙ = 1 and Δ−1W = D since the logit link is a
canonical link).
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Table 1: Empirical type-I error rates at 훼=0.05 for the logistic kernel machine test and
individual SNP analysis when applied to SNP sets simulated from the ASAH1 gene.
Individual Logististic Kernel Machine Test
n SNP Analysis Linear Kernel IBS Kernel Weighted IBS Kernel
1000 0.049 0.052 0.046 0.055
2000 0.048 0.047 0.053 0.052
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Table 2: Top results from the discovery phase of the CGEMS breast cancer GWAS.
SNP Chromosome Gene p-value
rs10510126 10 2.0×10−6
rs12505080 4 8.0×10−6
rs17157903 7 RELN 9.0×10−6
rs1219648 10 FGFR2 1.2×10−5
rs7696175 4 TLR1—TLR6 1.4×10−5
rs2420946 10 FGFR2 1.5×10−5
rs2107349 7 AZGP1—AZGP1P2 1.7×10−5
rs6497337 16 SYT17 2.0×10−5
rs1250255 2 FN1 3.4×10−5
rs10804287 2 3.8×10−5
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Table 3: Top results from the logistic kernel machine based SNP set analysis of the CGEMs
Breast Cancer Study data.
Linear IBS Weighted IBS
Gene 푝-value 푞-value 푝-value 푞-value 푝-value 푞-value
FGFR2 7.69×10−7 0.01 2.53×10−6 0.03 1.35×10−5 0.05
CNGA3 5.59×10−6 0.05 4.65×10−6 0.03 3.25×10−6 0.02
TBK1 1.30×10−5 0.07 3.28×10−6 0.03 5.48×10−6 0.02
VWA3B 1.53×10−5 0.07 7.84×10−6 0.03 3.99×10−6 0.02
PTCD3 5.50×10−5 0.20 9.02×10−6 0.03 3.78×10−6 0.02
XPOT 6.60×10−5 0.20 3.48×10−5 0.09 4.91×10−5 0.11
VAPB 9.79×10−5 0.22 4.51×10−5 0.10 8.11×10−5 0.14
SHC3 1.01×10−4 0.22 3.77×10−4 0.34 1.61×10−3 0.46
SFTPB 1.78×10−4 0.31 1.38×10−4 0.27 7.62×10−5 0.14
SPATA7 1.90×10−4 0.31 1.76×10−4 0.28 1.39×10−4 0.22
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Figure 1: Empirical Power for SNP sets based on ASAH1 and LD-plot for the 86 SNPs in
the ASAH1 gene based on the CEU sample from the International HapMap Project. The
typed SNPs are denoted with a triangle and the bottom panel shows the LD-structure of
the SNPs in the ASAH1 gene.
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Figure 2: Empirical Power for SNP sets based on ASAH1. The SNPs on the x-axis are
sorted by median 푅2 with the 14 typed SNPs which is shown in the bottom plot.
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Figure 3: Smoothed Empirical Power Curves as a function of media푅2 between the causal
SNP and the typed SNP for SNP sets based on a range of genes.
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Figure 4: Comparison of the power and type I error of the Logistic Kernel Machine Test,
the Wessel and Schork method, and Mukhopadhyay et al.’s approach, denoted by K, W,
and M respectively, under seven models. Power and size estimates are based on 500 and
1000 simulations, respectively. The blue line shows the expected type I error rate.
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